Blog

Reported Consolidated quarterly numbers for IOL Chemicals and Pharmaceuticals are:

Net Sales at Rs 563.18 crore in June 2023 down 0.32% from Rs. 565.01 crore in June 2022.

Quarterly Net Profit at Rs. 45.86 crore in June 2023 up 32.28% from Rs. 34.67 crore in June 2022.

EBITDA stands at Rs. 79.58 crore in June 2023 up 30.57% from Rs. 60.95 crore in June 2022.

IOL Chemicals EPS has increased to Rs. 7.81 in June 2023 from Rs. 5.91 in June 2022.

Some of the key points extracted from the data provided to NSE are as follows:

1. Company Information:
   • Company Name: IOL Chemicals and Pharmaceuticals Limited
   • Reporting Quarter: First quarter (April 1, 2023, to June 30, 2023)
   • Nature of Report: Standalone
   • Presentation Currency: INR (Indian Rupees)
2. Financial Performance:
   • Revenue from Operations: INR 5,631,800,000.00
   • Other Income: INR 70,600,000.00
   • Total Income: INR 5,702,400,000.00
   • Cost of Materials Consumed: INR 3,767,000,000.00
   • Employee Benefit Expense: INR 540,900,000.00
   • Finance Costs: INR 39,500,000.00
   • Depreciation, Depletion, and Amortisation Expense: INR 144,400,000.00
   • Other Expenses: INR 712,700,000.00
   • Total Expenses: INR 5,087,100,000.00
   • Profit Before Tax: INR 615,300,000.00
   • Profit After Tax: INR 462,100,000.00
3. Earnings Per Share:
   • Basic Earnings Per Share from Continuing Operations: INR 7.87 (per share)
   • Diluted Earnings Per Share from Continuing Operations: INR 7.87 (per share)
4. Segment-wise Analysis:
   • The company has three reportable segments: Chemical, Pharmaceutical, and Unallocated.
   • Chemical Segment Revenue: INR 3,008,400,000.00
   • Pharmaceutical Segment Revenue: INR 3,480,400,000.00
   • Unallocated Segment Revenue: INR 85,700,000.00
   • Total Segment Revenue: INR 6,574,500,000.00
5. Other Information:
   • The financial results have been reviewed by the Audit Committee and approved by the Board of Directors.
   • The financial results are audited and prepared in accordance with Indian Accounting Standards (Ind-AS).
   • The company operates in multiple segments, including Pharmaceuticals and Chemicals.
   • The consolidated financial results include results from subsidiary companies.
   • The company commenced its Acetic Anhydride Plant for Captive Consumption and Merchant Sale during the quarter.
   • The company’s previous financial period figures have been restated.

IOL Chemicals shares closed at 388.80 on August 09, 2023 (NSE) and has given 23.62% returns over the last 6 months and 11.37% over the last 12 months.

Please note that this summary is based on the extracted information from the provided data. For a comprehensive and accurate analysis, it’s recommended to review the complete XBRL document and consider any additional context or information related to the company’s financial performance. Additionally, if you require a more detailed analysis or specific insights from the financial data, feel free to provide further details or questions.